Ptcb Quiz: Error Prevention Strategies
20 questions · exam conditions
0:00
Error Prevention StrategiesQuestion 1 of 20

Besides storing look-alike/sound-alike drugs in completely different locations, which of the following is an effective strategy to reduce selection errors at the shelf?

Placing the medications in strict alphabetical order.
Using bold-colored shelf-talkers or warning labels.
Storing the faster-moving item in a more accessible location.
Keeping all strengths of the same drug lined up together.
← Back to quizzes

Ptcb Quiz

Ptcb Quiz: Error Prevention Strategies

Practice Error Prevention Strategies in Ptcb with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Error Prevention Strategies, giving you a quick way to practice the rules, question types, and explanations that matter most for Ptcb.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

Besides storing look-alike/sound-alike drugs in completely different locations, which of the following is an effective strategy to reduce selection errors at the shelf?

  1. Placing the medications in strict alphabetical order.
  2. Using bold-colored shelf-talkers or warning labels. (correct answer)
  3. Storing the faster-moving item in a more accessible location.
  4. Keeping all strengths of the same drug lined up together.
Explanation: Using auxiliary warnings such as brightly colored labels, stickers, or shelf-talkers that state "Look-Alike Drug" serves as a visual reminder to staff to be extra vigilant when selecting the medication. This strategy complements physical separation and Tall Man lettering. Storing alphabetically (A) is often the source of the problem. Storing by movement speed (C) or keeping strengths together (D) are inventory strategies that don't specifically address the LASA risk.

Question 2

A pharmacy technician is stocking a new shipment of medications and notices that the shelf labels for bupropion and buspirone are located next to each other. What is the most appropriate action to take?

  1. Place a "Look-Alike/Sound-Alike" warning sticker on both shelf labels.
  2. Inform the pharmacist and recommend separating the storage locations of these drugs. (correct answer)
  3. Use Tall Man lettering on the shelf labels but keep them in the same location.
  4. Ensure the bupropion is stocked in front of the buspirone to follow alphabetical order.
Explanation: Bupropion and buspirone are a well-known look-alike/sound-alike (LASA) pair. Storing them next to each other alphabetically increases the risk of a mix-up. The most appropriate and effective action is to alert the pharmacist to the risk and recommend physically separating their storage locations. Warning stickers and Tall Man lettering are useful auxiliary strategies, but physical separation is the most robust intervention.

Question 3

To comply with the Drug Supply Chain Security Act (DSCSA) and enhance medication safety, modern 2D barcodes on medication packages typically encode the NDC number, lot number, a unique serial number, and which other piece of information?

  1. Manufacturer's phone number
  2. Prescribing physician's DEA number
  3. Expiration date (correct answer)
  4. Patient's name
Explanation: Modern 2D barcodes are designed to carry more information than traditional linear barcodes. For DSCSA compliance, the four key data elements encoded on a package are the National Drug Code (NDC), a unique serial number, the lot number, and the expiration date. This information is critical for tracking, tracing, and verifying medications throughout the supply chain and for managing expired stock.

Question 4

A technician sees a handwritten order for "MS 10 mg." This abbreviation is considered dangerous and should be clarified because it could be misinterpreted as morphine sulfate or which other medication?

  1. Magnesium Sulfate (correct answer)
  2. Metformin Solution
  3. Multi-Symptom relief
  4. Methyl Salicylate
Explanation: The abbreviation "MS" is on the ISMP "Do Not Use" list because it has been dangerously confused for both Morphine Sulfate and Magnesium Sulfate. A mix-up between these two high-alert drugs can be fatal. Any prescription with this abbreviation requires immediate clarification with the prescriber before it is processed. The other options are not common misinterpretations.

Question 5

A pharmacy stocks both hydralazine 25 mg tablets and hydroxyzine 25 mg tablets. The bottles are similar in appearance.

To minimize the risk of a dispensing error involving these two medications, which of the following combinations of strategies would be most effective?

  1. Storing them alphabetically, side-by-side, to make them easy to find.
  2. Using Tall Man lettering (hydrALAZINE / hydrOXYzine) on the labels and storing them in separate, non-adjacent locations. (correct answer)
  3. Relying solely on the pharmacist's final check to catch any potential errors.
  4. Storing the less-frequently dispensed drug in the back of the shelf behind the more common one.
Explanation: The most effective approach to preventing errors with LASA drugs is to use multiple, layered safety strategies. Combining a visual aid like Tall Man lettering with a physical safeguard like inventory separation addresses the risk at different points. Storing them together (A) is dangerous. Relying on a single person's check (C) is not a robust system. Hiding one bottle behind another (D) is not a reliable method of separation.

Question 6

A pharmacy is implementing Tall Man lettering for its stock of look-alike/sound-alike medications. Which of the following is the correct application of this technique according to ISMP standards?

  1. hydrOXYzine and hydrALAZINE (correct answer)
  2. HYDROXYZINE and hydralazine
  3. Hydroxyzine and Hydralazine
  4. HYDRoxyzine and HYDRalazine
Explanation: The correct application of Tall Man lettering, as recommended by the Institute for Safe Medication Practices (ISMP), emphasizes the parts of the drug names that are different. For hydralazine and hydroxyzine, the correct format is hydrALAZINE and hydrOXYzine. The other options use capitalization incorrectly, which would not be effective at preventing confusion.

Question 7

What is the most effective strategy for arranging look-alike/sound-alike (LASA) medications on pharmacy shelves to prevent dispensing errors?

  1. Store them alphabetically next to each other for easy location.
  2. Store them in different, non-adjacent locations within the pharmacy. (correct answer)
  3. Store them on the same shelf but in different colored bins.
  4. Store the brand name drugs separately from the generics.
Explanation: The most effective way to prevent mix-ups between LASA medications is to physically separate them on the shelves (e.g., storing one in the 'A' section and the other in the 'Z' section, or on completely different rows). Storing them next to each other (A) increases the risk of a selection error. While colored bins (C) can be a helpful secondary strategy, physical separation is the primary recommendation. Separating brand from generic (D) is a general stocking strategy, not one specific to mitigating LASA risks.

Question 8

During the prescription filling process, what is the primary safety check accomplished by scanning the barcode on the manufacturer's stock bottle?

  1. It verifies that the medication's cost is correct in the billing system.
  2. It confirms that the medication has not expired.
  3. It matches the drug's NDC number to the one selected for the prescription. (correct answer)
  4. It documents the lot number for recall purposes.
Explanation: The primary safety function of barcode scanning during filling is to verify that the National Drug Code (NDC) on the stock bottle matches the NDC for the drug entered in the pharmacy system for that prescription. This ensures the correct medication, strength, and dosage form are being dispensed. While some modern barcodes contain expiration date (B) and lot number (D), the fundamental safety check is the NDC match. Cost (A) is a billing, not a clinical safety, function.

Question 9

A prescription is written for "Lisinopril 10 mg PO Q.D." Why is the abbreviation "Q.D." considered error-prone?

  1. It can be mistaken for "Q.I.D." (four times a day). (correct answer)
  2. It is an outdated Latin term that is no longer used.
  3. It can be confused with "Q.O.D." (every other day).
  4. It does not specify whether to take the medication with or without food.
Explanation: The abbreviation "Q.D." (once daily) is on the ISMP "Do Not Use" list because it can be easily misread as "Q.I.D." (four times daily), especially if the period after the 'Q' is mistaken for an 'I'. It can also be confused with "Q.O.D." (every other day). To avoid a potentially significant dosing error, the instruction should be written out as "daily" or "once daily".

Question 10

At which point in the medication-use process does bar code scanning provide a critical verification step to prevent a dispensing error in a community pharmacy?

  1. When transmitting the claim to the insurance company.
  2. When the patient picks up the prescription at the counter.
  3. When selecting the stock bottle from the shelf to fill the prescription. (correct answer)
  4. When ordering the medication from the wholesaler.
Explanation: In the prescription filling workflow, scanning the barcode on the stock bottle when it is selected from the shelf provides an electronic verification against the prescription being processed. This is a critical step to ensure the correct drug, strength, and formulation was chosen before the medication is counted and dispensed, thereby preventing wrong-drug errors. The other steps are important parts of the overall process but do not involve this specific safety check.

Question 11

Why is it a critical safety practice to always use a leading zero before a decimal point for doses less than one (e.g., "0.5 mg")?

  1. It is required by federal law for all prescriptions.
  2. It prevents the dose from being misread as a whole number. (correct answer)
  3. It helps the pharmacy software calculate the day's supply correctly.
  4. It clarifies the route of administration for the medication.
Explanation: The absence of a leading zero (e.g., writing ".5 mg") makes the decimal point easy to miss, which can lead to the dose being interpreted as 5 mg—a tenfold overdose. By always placing a zero before the decimal point for doses less than one, the decimal is emphasized, significantly reducing the risk of such an error. This is a widely accepted safety standard promoted by ISMP, not a specific federal law (A), and it is not related to calculations (C) or administration routes (D).

Question 12

A prescription for a liquid medication is written with the quantity "30 cc." To prevent errors, how should the pharmacy technician enter this into the pharmacy computer system?

  1. 30 g
  2. 30 mcg
  3. 30 mL (correct answer)
  4. 30 cc
Explanation: The abbreviation "cc" (cubic centimeter) is on the ISMP "Do Not Use" list because it can be poorly written and easily mistaken for "U" (units). The proper and unambiguous unit for liquid volume is milliliters (mL). Since 1 cc is equivalent to 1 mL, the correct and safe way to enter the quantity is as 30 mL. Continuing to use "cc" (D) perpetuates a risky practice. Grams (g) and micrograms (mcg) are units of mass, not volume.

Question 13

Which of the following dose notations is most likely to lead to a medication error due to the use of a trailing zero?

  1. 5 mg
  2. 0.5 mg
  3. 5.0 mg (correct answer)
  4. .5 mg
Explanation: A trailing zero (e.g., 5.0 mg) is considered an error-prone practice because the decimal point can be easily missed, causing the dose to be misread as 50 mg—a tenfold overdose. The ISMP recommends never using a trailing zero for doses expressed as whole numbers. In contrast, a leading zero (0.5 mg) is a safety feature, and its absence (.5 mg) is also considered error-prone.

Question 14

Which of the following best describes the primary purpose of using Tall Man lettering in a pharmacy setting?

  1. To highlight the recommended daily dose of a medication.
  2. To reduce medication errors between look-alike/sound-alike drug names. (correct answer)
  3. To indicate that a medication is a controlled substance.
  4. To comply with FDA requirements for medication labeling.
Explanation: The primary purpose of Tall Man lettering is to draw attention to the dissimilarities in drug names that look or sound alike, such as hydrOXYzine and hydrALAZINE. This practice helps pharmacy staff distinguish between them, reducing the risk of selecting the wrong medication. It is not used for dosage (A), controlled substance status (C), or as a universal FDA labeling requirement (D), although the FDA does support its use as a safety measure.

Question 15

Which of the following pairs of drug names is an appropriate candidate for using Tall Man lettering as an error-prevention strategy?

  1. Amoxicillin and Penicillin
  2. Metformin and Glipizide
  3. Lisinopril and Losartan
  4. Lamotrigine and Lamivudine (correct answer)
Explanation: Lamotrigine and Lamivudine are a classic look-alike/sound-alike pair that have been involved in harmful medication errors. The ISMP recommends using Tall Man lettering (lamoTRIgine / lamiVUDine) to help differentiate them. The other pairs do not have the same level of orthographic or phonetic similarity and are not on the standard ISMP list for Tall Man lettering.

Question 16

A pharmacy stores concentrated electrolytes, such as potassium chloride for injection, separately from other medications in a locked cabinet. This is an example of which error-prevention strategy?

  1. Bar code medication administration
  2. Separating inventory of high-alert medications (correct answer)
  3. Complying with DEA controlled substance storage rules
  4. Implementing a medication recall procedure
Explanation: Concentrated electrolytes are considered high-alert medications due to the risk of severe patient harm if administered incorrectly. A key safety strategy, advocated by organizations like the ISMP, is to segregate these medications from other stock to prevent inadvertent selection and administration. This practice is distinct from controlled substance regulations (C), barcode scanning (A), or recall procedures (D).

Question 17

Which organization is primarily responsible for creating and promoting the list of recommended look-alike/sound-alike drug names that should use Tall Man lettering?

  1. The Drug Enforcement Administration (DEA)
  2. The Food and Drug Administration (FDA)
  3. The Institute for Safe Medication Practices (ISMP) (correct answer)
  4. The state Board of Pharmacy (BOP)
Explanation: The Institute for Safe Medication Practices (ISMP), a non-profit organization focused on preventing medication errors, develops and maintains the official list of LASA drug names for which Tall Man lettering is recommended. While the FDA works with and supports the ISMP's efforts, the ISMP is the primary source for these safety standards. The DEA (A) regulates controlled substances, and the BOP (D) regulates pharmacy practice at the state level.

Question 18

A technician is using a handheld scanner to verify a medication during the filling process, but the barcode on the bottle is damaged and will not scan. What is the safest next step?

  1. Manually type the NDC number from the bottle into the computer system.
  2. Find another bottle of the same medication with a scannable barcode. (correct answer)
  3. Ask the pharmacist to visually verify the medication and override the scan.
  4. Bypass the scanning step and proceed with filling the prescription.
Explanation: The purpose of barcode scanning is to provide an automated, electronic verification that the correct product was selected. Bypassing this system introduces risk. The safest course of action is to locate another stock bottle of the identical medication that has a working barcode. This preserves the integrity of the safety check. Manually typing the NDC (A) is prone to transcription errors, and asking for an override (C) should be a last resort after all other options are exhausted.

Question 19

A pharmacy technician receives a prescription with the sig "Inject 10 U of insulin daily." According to the ISMP "Do Not Use" list, what is the safest way to interpret and enter this instruction?

  1. Enter the instruction as "Inject 10 units of insulin daily." (correct answer)
  2. Enter the instruction as "Inject 10 u of insulin daily."
  3. Ask the patient how they were told to take it before entering.
  4. Assume "U" means milliliters (mL) and enter "10 mL."
Explanation: The abbreviation "U" for units is on the ISMP's list of error-prone abbreviations because it can be easily mistaken for a zero ('0'), a four ('4'), or 'cc'. The safest practice is to always write out the word "units" in full. While clarification with the prescriber is ideal, the correct way to document it is by spelling out the word. Assuming it means mL (D) would be a dangerous error, and relying on the patient's memory (C) is not a reliable safety check for transcription.

Question 20

When a patient arrives to pick up a completed prescription, what is the most critical final verification step to prevent a medication error?

  1. Asking the patient to sign the electronic signature pad.
  2. Verifying the number of prescriptions being picked up.
  3. Scanning the barcode on the prescription receipt.
  4. Asking the patient to state their full name and date of birth. (correct answer)
Explanation: To prevent giving the correct medication to the wrong patient, the best practice is to use at least two patient identifiers. The technician should ask the patient to actively state their full name and date of birth. This information is then matched against the prescription label. Simply asking "Are you John Smith?" is less safe, as a patient might be distracted and agree incorrectly. Signing a log (A), counting prescriptions (B), or scanning a receipt (C) are process steps but do not confirm the patient's identity.